Dual Chamber Prefilled Syringes Market Driven by Biologics Demand

The dual chamber prefilled syringes market allows for the storage and delivery of two separate biologics, vaccines or drugs in one device

The dual chamber prefilled syringes market allows for the storage and delivery of two separate biologics, vaccines or drugs in one device. These syringes contain a piston to separate the main drug product chamber from the chamber containing diluents or other solutions. This format enables the mixing of the contents prior to injection and provides greater stability and control over the formulation. Dual chamber prefilled syringes are used for delivery of biologics that need to be reconstituted or mixed prior to use such as lyophilized drugs or hydrolytically unstable formulations. They eliminate errors from manual reconstitution and reduce liquid waste.

The Global dual chamber prefilled syringes market is estimated to be valued at US$ 171.8 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031.

Key Takeaways

The growing demand for biologics is a major driver for the Dual Chamber Prefilled Syringes Market Size. Biologics have revolutionized treatment landscapes but many need to be mixed or reconstituted before administration which dual chamber prefilled syringes enable in a convenient manner. The number of such biologics in development and approval is increasing rapidly.

Key players operating in the dual chamber prefilled syringes market are Pfizer Inc., NIPRO PHARMA CORPORATION, Gerresheimer AG, Vetter Pharma, Credence MedSystems, Inc., ARTE Corporation, BD, MAEDA INDUSTRY Co., Ltd., Bayer, Stevanato Group, Elcam Drug Delivery Devices, SCHOTT Pharma, OndrugDelivery Ltd, Catalent, Inc, Dätwyler Holding Inc. Pfizer and NIPRO dominate the market with their established portfolio of biologics that rely on dual chamber syringes for delivery.

Globally, many drug makers are expanding their prefilled syringe manufacturing capacities especially in Asia and Europe to cater to the global demand. For instance, Pfizer and MokXufture expanded their facilities in Ireland and China respectively in 2023. This will allow better access and affordability of dual chamber prefilled syringes worldwide.

Get More Insights On Dual Chamber Prefilled Syringes Market


Sherkhane Nishant

34 Blog posts

Comments